TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process
Aging · 2023
DOI: 10.18632/aging.204656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Xinyu Shao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215000, China.
- Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.
Zitieren
APA
Shao, X., Sun, Y., Zhong, K., Gu, J., Yu, Y., Hu, T., Kuai, X., & Xing, Y. (2023). TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process. Aging. https://doi.org/10.18632/aging.204656
Vancouver
Shao X, Sun Y, Zhong K, Gu J, Yu Y, Hu T, et al. TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process. Aging. 2023. doi:10.18632/aging.204656
BibTeX
@article{Shao2023,
author = {Shao, Xinyu and Sun, Yibin and Zhong, Kaiqiang and Gu, Jinrong and Yu, Yang and Hu, Tong and Kuai, Xiaoyi and Xing, Yechen},
title = {TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204656}
}
EUVIMED